Journal List > J Korean Med Sci > v.26(10) > 1021496

Choi, Kim, and Shin: The Author Response: Diagnostic Standardization of Leukemia Fusion Gene Detection System using Multiplex Reverse Transcriptase-polymerase Chain Reaction in Korea
We appreciated Dr Park TS for his interest and comments in our recent paper (1) in Journal of Korean Medical Science regarding a diagnostic standardization and detection methods of leukemia-associated gene rearrangements in Korea. Our study demonstrated the spectrum and frequency of chromosomal abnormalities in patients with mainly acute leukemia, which were differed from previous studies. Also, this study may offer important implications in the de-velopment of new molecular detection system for screening panel, as well as revisions of the current commercially available multiplex RT-PCR system. New molecular detection system for screening panel in our study means variety of molecular biological methods including PCR-based system, fluorescence in situ hybridization (FISH) and others. We agree that the FISH assay is better suited rather than the RT-PCR method in t(3;3)(q21;q26), inv(3)(q21q26), t(8;14)(q24;q32), and i(17)(q10).
However, one can use RT-PCR detection system for screening the aforementioned chromosomal abnormalities based on the following backgrounds. First, the protocol of RT-PCR assay for the detection of either inv(3)(q21q26) or t(3;3)(q21;q26) was already published (2). This protocol might be used in multiplex RT-PCR system for the detection of leukemia fusion genes. Second, it is well known that the t(8;14)(q24;q32) (c-myc/IgH rearrangement) has no fusion transcript and fusion protein (3). So, the c-myc/IgH rearrangement is only detectable at the DNA level (the RNA expression of c-myc (exon 1 or exon 2) and/or IgH (constant and joining region) also might be absent or remarkable depressed). Based on the fact of decrease or absence of RNA expression of these genes in the case of t(8;14)(q24;q32), conventional RT-PCR and quantitative RT-PCR for them might be implemented for screening. Genomic DNA PCR (long-distance) assay for the detection of the t(8;14)(q24;q32) was already established using one primer for the c-myc gene in exon 2 and four primers for the IgH locus (3, 4). Third, similarly, the screening of i(17)(q10) chromosomal abnormality by semiquantitative RT- PCR assay might be possible based on the absence of expression of p53 gene located at 17p13.1 due to deletion of short arm of 17 chromosome.

References

1. Choi HJ, Kim HR, Shin MG, Kook H, Kim HJ, Shin JH, Suh SP, Ryang DW. Spectra of chromosomal aberrations in 325 leukemia patients and implications for the development of new molecular detection systems. J Korean Med Sci. 2011. 26:886–892.
2. Martinelli G, Ottaviani E, Buonamici S, Isidori A, Borsaru G, Visani G, Piccaluga PP, Malagola M, Testoni N, Rondoni M, Nucifora G, Tura S, Baccarani M. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts. Haematologica. 2003. 88:1221–1228.
3. Mussolin L, Basso K, Pillon M, D'Amore ES, Lombardi A, Luzzatto L, Zanesco L, Rosolen A. Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32). Leukemia. 2003. 17:585–589.
4. Busch K, Borkhardt A, Wossmann W, Reiter A, Harbott J. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis. Haematologica. 2004. 89:818–825.
TOOLS
Similar articles